NCT00117910View on ClinicalTrials.gov

Treatment for Elderly Patients With High Risk Breast Cancer

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2002

Study Completion Date

May 31, 2004

Conditions
Breast Cancer
Interventions
DRUG

pegfilgrastim

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY